个性化文献订阅>期刊> European Journal of Medicinal Chemistry
 

Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo

  作者 Dong, ZX; Tan, RK; Cao, J; Yang, Y; Kong, CF; Du, J; Zhu, S; Zhang, Y; Lu, J; Huang, BQ; Liu, SX  
  选自 期刊  European Journal of Medicinal Chemistry;  卷期  2011年46-6;  页码  2477-2484  
  关联知识点  
 

[摘要]We obtained 5 positive novel histone deacetylase inhibitors (HDACIs) from a polyoxometalate (POM) library by using a cell-based screening system targeting the p21 gene promoter. Among them, PAC-320, a new tri-organic-tin-substitute germanotungstate, displayed remarkable extracellular inhibitory activity. Meanwhile, the crystal structure of PAC-320 was characterized by X-ray crystallography. PAC-320 could stably exist under physiological conditions as revealed by UV spectrum, CV and TG. PAC-320 possessed a strong inhibitory effect to intracellular HDAC activity. More significantly, PAC-320 inhibited the growth of a variety of cancer cells, and exhibited remarkable anticancer effect in a hepatocarcinoma H22 cell mice model. This study revealed, for the first time, that the HDAC inhibitory activity is a mechanism by which POMs exert their anticancer effect. (C) 2011 Elsevier Masson SAS. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内